• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Musculoskelet Disord . Evaluation of early complications, outcome, and mortality in Coronavirus Disease 2019 (COVID-19) infection in patients w

tetano

Editor, Senior Moderator
BMC Musculoskelet Disord


. 2022 Jan 18;23(1):64.
doi: 10.1186/s12891-022-05010-8.
Evaluation of early complications, outcome, and mortality in Coronavirus Disease 2019 (COVID-19) infection in patients who underwent orthopedic surgery


Mehdi Mohammadpour[SUP] 1 [/SUP], Hamidreza Yazdi[SUP] 1 [/SUP], Abolfazl Bagherifard[SUP] 1 [/SUP], Mahmoud Jabalameli[SUP] 1 [/SUP], Mehdi Moghtadaei[SUP] 1 [/SUP], Ali Torkaman[SUP] 1 [/SUP], Hooman Yahyazadeh[SUP] 1 [/SUP], Mohammad Taher Ghaderi[SUP] 1 [/SUP], Mohammad Mahdi Fanaeian[SUP] 2 [/SUP], Moein Khaleghi Langeroudi[SUP] 1 [/SUP], Peyman Hashemi[SUP] 1 [/SUP], Saeed Razi[SUP] 1 [/SUP], Amer Karimpour[SUP] 1 [/SUP], Sam Bemani Lirgeshasi[SUP] 1 [/SUP], Milad Bahari[SUP] 3 [/SUP]



Affiliations

Abstract

Background: A higher mortality and morbidity rate has been reported in COVID-19 patients undergoing surgery. To reduce the morbidity and mortality rate in COVID-19 patients undergoing orthopedic procedures, we aimed to increase the threshold for surgical planning.
Methods: In a prospective cohort study, COVID-19 patients who underwent elective or emergent orthopedic surgery in three orthopedic surgery centers from February 2020 to September 2020 were included. In this period, 6751 patients were scheduled for orthopedic surgery. To increase surgical threshold planning, all patients with grade 5 of the American Society of Anesthesiologists (ASA) classification and patients with COVID-19 related moderate to severe pulmonary involvement were identified as high-risk patients and were excluded.
Results: 35 deaths occurred during the study. The frequency of deaths was significantly higher in patients with COVID-19, 6 (9.4%) than patients without COVID-19, 29 (0. 43%). The average hospitalization stay was 12.8 ± 12.1 days. The odds ratio (OR) for death was significantly higher in patients with COVID-19 than patients without COVID-19. [OR: 8.13, Confidence interval 95% (CI95%) (5.02-11.25), P: 0.001]. Four (6.3%) COVID-19-associated complications were recorded in this series that all were respiratory failure requiring unexpected postoperative ventilation. Twenty surgical complications (31.3%) were recorded. The odds ratio for ICU admission was significantly higher in patients with COVID-19 than patients without COVID-19. [OR: 5.46, CI 95% (2.68-8.68), P: 0.001].
Conclusions: An increased threshold for orthopedic surgery is suggested for COVID-19 patients with a mortality rate of 9.3%, which is less than the mortality rate in other studies. Level of evidence III.

Keywords: COVID-19; Mortality; Orthopedic procedures; Threshold.
 
Back
Top Bottom